Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine for Prevention of AKI-CKD Continuum
NCT05325099Phase 2Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in acute kidney injury (AKI), sponsored by National Taiwan University Hospital. Started Apr 2024; status: recruiting.
02
Drugs
azacitidine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05325099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05325099.